Since BMSN will be the primary shareholder of Regen @ 58%, the valuation of Regen will drive BMSN's price, not the other way around.
The share price of Regen will not be set until it's traded, so there is no calculation anyone can do to predict the price of either.
The only point you can calculate is previous distributions, which was 4 instances of private distributions of 100,000 shares in consideration of $100,000, ergo, $1 per share. Most consider private distributions or sales are given at a great discount, so draw your own conclusions.
However, the average of the recent IPOs for biotech stocks this year are anywhere from $5-$15 per share. All of them are also currently not producing anything,or "pre-commercial" if you will. Meaning they are in the testing phases. So, again, draw your own conclusions.
